Segui questo link per vedere altri tipi di pubblicazioni sul tema: Mitochondrial diseases.

Libri sul tema "Mitochondrial diseases"

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 libri per l'attività di ricerca sul tema "Mitochondrial diseases".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi i libri di molte aree scientifiche e compila una bibliografia corretta.

1

James, Holt Ian, a cura di. Genetics of mitochondrial diseases. Oxford: Oxford University Press, 2003.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Navas, Placido, e Leonardo Salviati, a cura di. Mitochondrial Diseases. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-70147-5.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Lestienne, Patrick, a cura di. Mitochondrial Diseases. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-59884-5.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

service), ScienceDirect (Online, a cura di. Mitochondrial function: Mitochondrial protein kinases, protein phosphatases and mitochondrial diseases. San Diego, Calif: Academic Press/Elsevier, 2009.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

N, Gellerich Frank, Zierz S e Colloquium on Mitochondria and Myopathies (1st : 1995 : Halle an der Saale, Germany), a cura di. Detection of mitochondrial diseases. Dordrecht: Kluwer Academic, 1997.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Sun, Hongzhi, e Xiangdong Wang, a cura di. Mitochondrial DNA and Diseases. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-6674-0.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Gellerich, Frank Norbert, e Stephan Zierz, a cura di. Detection of Mitochondrial Diseases. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4615-6111-8.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Anna, Gvozdjáková, a cura di. Mitochondrial medicine: Mitochondrial metabolism, diseases, diagnosis and therapy. Dordrecht: Springer, 2008.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

V, Schapira Anthony H., e DiMauro S, a cura di. Mitochondrial disorders in neurology. Oxford: Butterworth-Heinemann, 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

S, DiMauro, Hirano Michio e Schon Eric A, a cura di. Mitochondrial medicine. Abingdon [U.K.]: Informa Healthcare, 2006.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
11

Mitochondrial medicine. New York: Humana Press, 2015.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
12

Mitochondrial dysfunction and oxidativedamage in neurodegenerative diseases. New York: Springer, 1995.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
13

M, Smeitink Jan A., Sengers Rob C. A e Trijbels J. M. Frans, a cura di. Oxidative phosphorylation in health and disease. Georgetown, Tex., U.S.A: Landes Bioscience/Eurekah.com, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
14

Beal, M. Flint. Mitochondrial dysfunction and oxidative damage in neurodegenerative diseases. Austin: R.G. Landes Co., 1995.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
15

C, St John Justin, a cura di. The mitochondrion in the germline and early development. San Diego, Calif: Academic Press, 2007.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
16

Advances in mitochondrial medicine. Dordrecht: Springer Verlag, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
17

Mitochondrial signaling in health and disease. Boca Raton: Taylor & Francis/CRC Press, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
18

Reeve, Amy Katherine. Mitochondrial Dysfunction in Neurodegenerative Disorders. London: Springer-Verlag London Limited, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
19

Hidaka, Takuya. Sequence-Specific DNA Binders for the Therapy of Mitochondrial Diseases. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-8436-4.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
20

R, Sanberg Paul, Nishino Hitoo e Borlongan Cesario V, a cura di. Mitochondrial inhibitors and neurodegenerative disorders. Totowa, N.J: Humana Press, 2000.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
21

Marín-García, José. Mitochondria and their role in cardiovascular disease. New York: Springer, 2013.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
22

Mitochondrial Diseases: Models and Methods. Springer, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
23

Lestienne, Patrick. Mitochondrial Diseases: Models and Methods. Springer London, Limited, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
24

Lestienne, Patrick. Mitochondrial Diseases: Models and Methods. Springer, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
25

Lestienne, Patrick, a cura di. Mitochondrial Diseases: Models and Methods. SPRINGER-VERLAG, 1999.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
26

Gorman, Gráinne S., e Patrick F. Chinnery. Mitochondrial diseases. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199658602.003.0011.

Testo completo
Abstract (sommario):
This chapter critiques ten seminal papers that epitomize the advent and evolution of mitochondrial medicine from the latter half of the last century up until today. These important bodies of work span the pre-molecular and molecular eras, from when diagnostic yield was based on meticulous clinical and biochemical characterization of patients, up until now, with targeted next-generation sequencing revolutionizing our diagnostic approach. The first clinical description of a mitochondrial disorder is reviewed and the subsequent landmark papers that define current clinical and molecular understanding of human diseases caused by inherited disorders of mitochondrial dysfunction are chronicled. The chapter also charts the shift in emphasis from diagnosis to the development of treatments and novel approaches for disease prevention.
Gli stili APA, Harvard, Vancouver, ISO e altri
27

Taskin, Eylem, Celal Guven e Yusuf Sevgiler, a cura di. Mitochondrial Diseases. InTech, 2018. http://dx.doi.org/10.5772/67963.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
28

Wiley. Mitochondrial Diseases. Wiley & Sons, Incorporated, John, 2013.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
29

Taskin, Eylem, Celal Guven e Yusuf Sevgiler. Mitochondrial Diseases. IntechOpen, 2018.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
30

Wiley. Mitochondrial Diseases. Wiley & Sons, Incorporated, John, 2013.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
31

Hirano, Michio, Rita Horvath e Patrick Francis Chinnery. Mitochondrial Diseases. Elsevier, 2022.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
32

Horvath, Rita, MIchi Hirano e Patrick Francis Chinnery. Mitochondrial Diseases. Elsevier, 2022.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
33

Berdanier, Carolyn D. Mitochondria in Health and Disease. Taylor & Francis Group, 2005.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
34

Mitochondria in health and disease. Boca Raton, Fla: Dekker, 2005.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
35

Berdanier, Carolyn D. Mitochondria in Health and Disease. Taylor & Francis Group, 2005.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
36

Knott, Andrew B., e Ella Bossy-Wetzel. Mitochondrial Changes and Bioenergetics in Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0012.

Testo completo
Abstract (sommario):
Mitochondria are dynamic organelles that are of critical importance for cellular survival and health. Because mitochondria play central roles in energy production and synaptic maintenance, neurons are believed to be particularly vulnerable to mitochondrial dysfunction. The discovery that genetic mutations in genes coding for mitochondrial proteins cause neurodegenerative conditions further hinted at the likelihood that mitochondrial dysfunction is a key pathway of neurodegeneration. Indeed, a wealth of research has identified mitochondrial dysfunction as an early and shared event of all common neurodegenerative diseases, both genetic and sporadic in origin. Specific types of mitochondrial dysfunction that have been observed in most neurodegenerative diseases include bioenergetic failure, increased oxidative stress, mitochondrial DNA mutations, defective calcium handling, impaired mitochondrial dynamics, defective mitophagy, and decreased mitochondrial biogenesis. The search for drugs that successfully target these pathways of mitochondrial dysfunction in neurodegeneration is ongoing.
Gli stili APA, Harvard, Vancouver, ISO e altri
37

Wang, Xiangdong, e Hongzhi Sun. Mitochondrial DNA and Diseases. Springer, 2018.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
38

Mitochondrial Diseases [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.91518.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
39

Detection of Mitochondrial Diseases. Springer, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
40

Wang, Xiangdong, e Hongzhi Sun. Mitochondrial DNA and Diseases. Springer, 2017.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
41

Mitochondrial DNA and Diseases. Springer, 2017.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
42

Gellerich, F. N. Detection of Mitochondrial Diseases. Springer, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
43

Gellerich, F. N., e S. Zierz. Detection of Mitochondrial Diseases. Springer London, Limited, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
44

Mitochondrial function and dysfunction. Amsterdam: Academic Press, 2002.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
45

Gvozdjáková, Anna. Mitochondrial Medicine: Mitochondrial Metabolism, Diseases, Diagnosis and Therapy. Springer, 2014.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
46

(Contributor), S. Di Mauro, a cura di. Mitochondrial Disorders. Springer, 2002.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
47

Mitochondrial Function, Part B: Mitochondrial Protein Kinases, Protein Phosphatases and Mitochondrial Diseases. Elsevier, 2009. http://dx.doi.org/10.1016/s0076-6879(09)x0026-1.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
48

Weissman, Jacqueline, e Lisa Emrick. Diseases of Mitochondrial Energy Metabolism. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0061.

Testo completo
Abstract (sommario):
Mitochondrial disorders are a group of inherited diseases of energy metabolism caused by impairment of mitochondrial function-primarily disorders of the oxidative phosphorylation system but also the more recently described disorders of mitochondrial transport and fission. This review will focus on primary disorders of mitochondrial oxidative phosphorylation. The neurologic system is one of the most profoundly affected by mitochondrial dysfunction and the effects can be varied and widespread. This has led to these diseases being commonly called mitochondrial encephalomyopathies. The heterogeneity of clinical presentation, laboratory findings, neuroimaging findings, pathologic findings, and genetic findings in these diseases make diagnosis extremely difficult. Treatment for mitochondrial disorders is currently lacking a solid evidence base but this is a rapidly expanding area of research.
Gli stili APA, Harvard, Vancouver, ISO e altri
49

Hall, Andrew, e Shamima Rahman. Mitochondrial diseases and the kidney. A cura di Neil Turner. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0340.

Testo completo
Abstract (sommario):
Mitochondrial disease can affect any organ in the body including the kidney. As increasing numbers of patients with mitochondrial disease are either surviving beyond childhood or being diagnosed in adulthood, it is important for all nephrologists to have some understanding of the common renal complications that can occur in these individuals. Mitochondrial proteins are encoded by either mitochondrial or nuclear DNA (mtDNA and nDNA, respectively); therefore, disease causing mutations may be inherited maternally (mtDNA) or autosomally (nDNA), or can arise spontaneously. The commonest renal phenotype in mitochondrial disease is proximal tubulopathy (Fanconi syndrome in the severest cases); however, as all regions of the nephron can be affected, from the glomerulus to the collecting duct, patients may also present with proteinuria, decreased glomerular filtration rate, nephrotic syndrome, water and electrolyte disorders, and renal tubular acidosis. Understanding of the relationship between underlying genotype and clinical phenotype remains incomplete in mitochondrial disease. Proximal tubulopathy typically occurs in children with severe multisystem disease due to mtDNA deletion or mutations in nDNA affecting mitochondrial function. In contrast, glomerular disease (focal segmental glomerulosclerosis) has been reported more commonly in adults, mainly in association with the m.3243A<G point mutation. Co-enzyme Q10 (CoQ10) deficiency has been particularly associated with podocyte dysfunction and nephrotic syndrome in children. Underlying mitochondrial disease should be considered as a potential cause of unexplained renal dysfunction; clinical clues include lack of response to conventional therapy, abnormal mitochondrial morphology on kidney biopsy, involvement of other organs (e.g. diabetes, cardiomyopathy, and deafness) and a maternal family history, although none of these features are specific. The diagnostic approach involves acquiring tissue (typically skeletal muscle) for histological analysis, mtDNA screening and oxidative phosphorylation (OXPHOS) complex function tests. A number of nDNA mutations causing mitochondrial disease have now been identified and can also be screened for if clinically indicated. Management of mitochondrial disease requires a multidisciplinary approach, and treatment is largely supportive as there are currently very few evidence-based interventions. Electrolyte deficiencies should be corrected in patients with urinary wasting due to tubulopathy, and CoQ10 supplementation may be of benefit in individuals with CoQ10 deficiency. Nephrotic syndrome in mitochondrial disease is not typically responsive to steroid therapy. Transplantation has been performed in patients with end-stage kidney disease; however, immunosuppressive agents such as steroids and tacrolimus should be used with care given the high incidence of diabetes in mitochondrial disease.
Gli stili APA, Harvard, Vancouver, ISO e altri
50

Sciarretta, Sebastiano, Richard N. Kitsis e Junichi Sadoshima, a cura di. Mitochondrial Dysfunction and Cardiovascular Diseases. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88966-556-3.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!

Vai alla bibliografia